Unichem Pharmaceuticals appoints new CEO

| By | Drug Development, Pharmaceutical Manufacturing
0
142

Unichem Pharmaceuticals, a Hasbrouck Heights, New Jersey, USA, based specialty generic pharmaceutical company, announced that Scott Delaney has joined the Company as President and Chief Executive Officer – North America for the Company’s parent, Unichem Laboratories Limited, based in Mumbai, India. Mr. Delaney has also been appointed as a member of the Company’s Board of Directors

Mr. Delaney is an accomplished leader with over 24 years of experience in brand and generic pharmaceutical management. He brings deep expertise in many areas of generic pharmaceutical management, including sales, marketing, contract negotiation, business development, manufacturing/distribution, third party payor management, product portfolio selection and product life cycle management.

Mr. Delaney has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, and Edenbridge Pharmaceuticals. Most recently, Mr. Delaney was President of Heritage Pharmaceuticals, Inc., a division of Emcure Pharmaceuticals based in Pune, India.

Unichem Pharmaceuticals (USA), Inc. is a specialty pharmaceutical company engaged in the development, marketing and distribution of generic pharmaceutical products in the United States.

SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.